MarylandHB 14612026 Regular SessionHouse

Health Insurance - Coverage for Specialty Drugs - Rheumatologic Conditions

Sponsored By: Deni Taveras (Democratic)

In Committee

Health - InsuranceDrugs -see also- Cannabis; ControlDangSubst; Pharm; etc.Health -see also- COVID19; EnvHlth; MedCon; etc.Health Insurance -see also- ACA; HMOs; MCOsHealth Maintenance Organizations -see also- Manage Care OrgsMedical Conditions -see also- AIDS; COVID-19; rabiesMedical TreatmentsNonprofit OrganizationsPharmacy Benefits ManagersPharmacists and Pharmacies -see also- Drugs

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & Cosponsors

Sponsor

  • Deni Taveras

    Democratic • House

Cosponsors

  • Mary A. Lehman

    Democratic • House

  • Nicole A. Williams

    Democratic • House

Roll Call Votes

No roll call votes available for this bill.

Actions Timeline

  1. Hearing 3/13 at 1:30 p.m.

    3/13/2026House
  2. Hearing canceled

    3/13/2026House
  3. Hearing 3/13 at 3:00 p.m.

    3/13/2026House
  4. Hearing canceled

    3/13/2026House
  5. Hearing 3/13 at 1:00 p.m.

    2/13/2026House
  6. First Reading Health

    2/13/2026House

Bill Text

  • First Reading

    2/13/2026

Related Bills

Back to State Legislation